| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0086 | 0.9 |